We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$68.5B
AUM Growth
-$9.16B
Cap. Flow
+$4.06B
Cap. Flow %
5.93%
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,434
Reduced
285
Closed
282

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$124M
2
AAPL icon
Apple
AAPL
+$110M
3
MSFT icon
Microsoft
MSFT
+$104M
4
AMZN icon
Amazon
AMZN
+$71.3M
5
WBD icon
Warner Bros
WBD
+$69.6M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$61.6M
2
CERN
Cerner Corp
CERN
+$50.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$31.4M
4
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$30.4M
5
YUMC icon
Yum China
YUMC
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 14.42%
3 Financials 13.45%
4 Consumer Discretionary 10.49%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFIB
3276
DELISTED
Acutus Medical Inc
AFIB
-12,238
Closed -$17K
FUV
3277
DELISTED
Arcimoto, Inc. Common Stock
FUV
-1,390
Closed -$184K
CBAY
3278
DELISTED
Cymabay Therapeutics
CBAY
-101,595
Closed -$316K
BCEL
3279
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-30,359
Closed -$96K
CYT
3280
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
-12,555
Closed -$47K
BFX
3281
DELISTED
BowFlex Inc.
BFX
-35,145
Closed -$145K
SIEN
3282
DELISTED
Sientra, Inc.
SIEN
-5,756
Closed -$128K
RAIN
3283
DELISTED
Rain Oncology Inc. Common Stock
RAIN
-11,319
Closed -$57K
SRT
3284
DELISTED
Startek Inc.
SRT
-17,716
Closed -$78K
ONCT
3285
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-2,616
Closed -$73K
AMTI
3286
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
-24,335
Closed -$183K
VAPO
3287
DELISTED
Vapotherm, Inc. Common Stock
VAPO
-2,936
Closed -$327K
GHL
3288
DELISTED
Greenhill & Co., Inc.
GHL
-37,460
Closed -$580K
TRHC
3289
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-23,956
Closed -$138K
FRGI
3290
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
-69,658
Closed -$521K
LTRPA
3291
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
-85,498
Closed -$175K
PRTK
3292
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-44,588
Closed -$132K
INFI
3293
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-80,564
Closed -$92K
SURF
3294
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-41,388
Closed -$122K
HARP
3295
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-1,724
Closed -$86K
IDEX
3296
DELISTED
Ideanomics, Inc. Common Stock
IDEX
-4,647
Closed -$651K
MTEM
3297
DELISTED
Molecular Templates, Inc.
MTEM
-2,213
Closed -$115K
SPPI
3298
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-162,991
Closed -$210K
HGEN
3299
DELISTED
HUMANIGEN, INC.
HGEN
-46,361
Closed -$140K
NMTR
3300
DELISTED
9 Meters Biopharma
NMTR
-7,733
Closed -$93K

Similar funds

RhumbLine Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,434 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.

  • RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
  • RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
  • RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
  • RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
  • RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
  • RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.